Hanson & Doremus Investment Management reduced its position in shares of Stericycle Inc (NASDAQ:SRCL) by 2.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 29,893 shares of the business services provider’s stock after selling 788 shares during the period. Hanson & Doremus Investment Management’s holdings in Stericycle were worth $1,907,000 at the end of the most recent quarter.
Other institutional investors have also recently made changes to their positions in the company. Texas Permanent School Fund boosted its stake in Stericycle by 6.8% during the 3rd quarter. Texas Permanent School Fund now owns 62,020 shares of the business services provider’s stock worth $3,159,000 after purchasing an additional 3,940 shares during the last quarter. Northern Trust Corp boosted its holdings in shares of Stericycle by 3.7% during the 2nd quarter. Northern Trust Corp now owns 880,250 shares of the business services provider’s stock worth $42,031,000 after purchasing an additional 31,193 shares during the last quarter. UBS Asset Management Americas Inc. grew its position in shares of Stericycle by 8.4% in the second quarter. UBS Asset Management Americas Inc. now owns 3,608,752 shares of the business services provider’s stock valued at $172,318,000 after purchasing an additional 278,461 shares in the last quarter. Morgan Stanley grew its position in shares of Stericycle by 45.2% in the second quarter. Morgan Stanley now owns 321,103 shares of the business services provider’s stock valued at $15,333,000 after purchasing an additional 99,941 shares in the last quarter. Finally, Envestnet Asset Management Inc. grew its position in shares of Stericycle by 10.1% in the third quarter. Envestnet Asset Management Inc. now owns 103,937 shares of the business services provider’s stock valued at $5,294,000 after purchasing an additional 9,507 shares in the last quarter.
A number of equities analysts recently commented on the company. Jefferies Financial Group assumed coverage on Stericycle in a research report on Wednesday, November 27th. They set a “hold” rating and a $68.00 price objective on the stock. BidaskClub downgraded Stericycle from a “buy” rating to a “hold” rating in a research note on Friday, December 13th. ValuEngine lowered Stericycle from a “hold” rating to a “sell” rating in a report on Wednesday, December 18th. Royal Bank of Canada began coverage on Stericycle in a report on Wednesday, November 27th. They set an “outperform” rating and a $75.00 price target on the stock. Finally, TheStreet raised shares of Stericycle from a “d+” rating to a “c-” rating in a research report on Thursday, October 31st. Three analysts have rated the stock with a sell rating, four have given a hold rating and three have issued a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus price target of $57.43.
Stericycle (NASDAQ:SRCL) last released its quarterly earnings results on Thursday, October 31st. The business services provider reported $0.80 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.68 by $0.12. The firm had revenue of $833.10 million for the quarter, compared to analyst estimates of $842.21 million. Stericycle had a negative net margin of 13.26% and a positive return on equity of 10.52%. The business’s revenue for the quarter was down 2.6% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.03 EPS. As a group, equities research analysts expect that Stericycle Inc will post 2.63 earnings per share for the current year.
In other news, EVP Daniel Ginnetti sold 6,000 shares of Stericycle stock in a transaction that occurred on Thursday, October 31st. The shares were sold at an average price of $55.47, for a total transaction of $332,820.00. Following the sale, the executive vice president now owns 15,943 shares of the company’s stock, valued at approximately $884,358.21. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 2.30% of the stock is currently owned by insiders.
Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. It operates through three segments: Domestic and Canada Regulated Waste and Compliance; International Regulated Waste and Compliance; and Domestic Communication and Related Services.
Want to see what other hedge funds are holding SRCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stericycle Inc (NASDAQ:SRCL).
Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.